PROBLEM TO BE SOLVED : To provide new salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them. SOLUTION : The present invention provides abexinostat tosylate of formula II, and a crystalline form I of the abexinostat tosylate characterized by its powder diffraction pattern X, its Raman spectrum, and its solid 13C CP/MAS NMR spectrum. SELECTED DRAWING : None COPYRIGHT : (C)2019, JPO&INPIT